[Frontiers in Bioscience S6, 65-74, January 1, 2014] 65 Parkinson’s disease: a review Janice M.
Beitz1 1School of Nursing-Camd Page 1 [Frontiers in Bioscience S6, 65-74, January 1, 2014] …

Parkinson's disease is a common movement disorder seen in neurological practice, but the
diagnosis and management is challenging. The diagnosis is clinical and sometimes difficult …

Methods We used Canadian and American national guidelines to inform this review, in
addition to published systematic reviews that were known to us. We identified additional …

Abstract The Movement Disorder Society (MDS) Task Force on Evidence‐Based Medicine
(EBM) Review of Treatments for Parkinson's Disease (PD) was first published in 2002 and …

Parkinson's disease (PD) is usually characterized by cardinal motor impairments. However,
a range of non-motor symptoms precede the motor-phase and are major determinants for …

Parkinsonism is a progressive motor disease that affects 1.5 million Americans and is the
second most common neurodegenerative disease after Alzheimer's. Typical …

The demonstration that dopamine loss is the key pathological feature of Parkinson's disease
(PD), and the subsequent introduction of levodopa have revolutionalized the field of PD …

Inhibitors of catechol-O-methyltransferase (COMT) are commonly used as an adjunct to
levodopa in patients with Parkinson's disease (PD) for the amelioration of wearing-off …

Parkinson's disease (PD) is a multi-systemic disorder that is characterized by a combination
of motor and non-motor symptoms (NMS). The dopaminergic neurodegeneration of PD is …

Alzheimer's disease (AD) and Parkinson's disease (PD) have markedly different clinical and
pathological features, but these two diseases are the most common neurodegenerative …